The Efficacy of Reducing Rifampicin Resistant Pulmonary Tuberculosis Transmission by Using Genotypic Rapid Diagnostic Tools.
碩士 === 國立臺北護理健康大學 === 健康事業管理研究所 === 106 === BACKGROUND: Rifampicin-resistant pulmonary tuberculosis (RR-TB) is an emerging public health threat globally. In 2015, it is estimated that 580000 patients developed RR-TB globally. Among them, about 480000 patients were multidrug-resistant tuberculosis. G...
Main Authors: | CHAO, CHIEN-PING, 趙蒨萍 |
---|---|
Other Authors: | CHIOU, SHANG-JYH |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/8uay34 |
Similar Items
-
Assessment of diagnostic accuracy of GeneXpert Mycobacterium tuberculosis/rifampicin in diagnosis of pulmonary tuberculosis in Kosovo
by: Rrezarta Bajrami, et al.
Published: (2018-01-01) -
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda
by: Ngabonziza, J.-C.S., et al.
Published: (2020) -
Rapid tests reduce the burden of tuberculosis in Azerbaijan prisons: special emphasis on rifampicin-resistance
by: E Gurbanova, et al. -
GeneXpert: A new tool for the rapid detection of rifampicin resistance in mycobacterium tuberculosis
by: M. Saeed
Published: (2020-12-01) -
Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)